These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34293194)

  • 1. Clinical safety evaluation of contrast agents based on real-world evidence.
    Jiang C; Li J; Huang Y; Huang D; Lin J; Jiang X
    J Clin Pharm Ther; 2021 Dec; 46(6):1600-1605. PubMed ID: 34293194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactions to Both Nonionic Iodinated and Gadolinium-Based Contrast Media: Incidence and Clinical Characteristics.
    Sodagari F; Mozaffary A; Wood CG; Schmitz B; Miller FH; Yaghmai V
    AJR Am J Roentgenol; 2018 Apr; 210(4):715-719. PubMed ID: 29412016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Adverse Reactions Among Iodinated Contrast Media: Analysis of the KAERS Database.
    An J; Jung H; Kwon OY; Kang Y; Lee JH; Won HK; Song WJ; Kwon HS; Cho YS; Moon HB; Kim TB
    J Allergy Clin Immunol Pract; 2019; 7(7):2205-2211. PubMed ID: 30877072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-marketing surveillance study with iodixanol in 20 185 Chinese patients from routine clinical practices.
    Zhang BC; Hou L; Lv B; Xu YW
    Br J Radiol; 2014 Feb; 87(1034):20130325. PubMed ID: 24357597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of the incidence of hypersensitivity reactions and post-contrast acute kidney injury after ioversol: part 2-intra-arterial administration.
    van der Molen AJ; Dekkers IA; Bedioune I; Darmon-Kern E
    Eur Radiol; 2022 Aug; 32(8):5546-5558. PubMed ID: 35312791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate and delayed hypersensitivity after intra-arterial injection of iodinated contrast media: a prospective study in patients with coronary angiography.
    Sohn KH; Kim GW; Lee SY; Kim HS; Cho SH; Han JK; Kang HR
    Eur Radiol; 2019 Oct; 29(10):5314-5321. PubMed ID: 30937592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast Media Adverse Drug Reactions in Highly Polluted Environment.
    Sauer N; Szlasa W; Jonderko L; Głowacka K; Karłowicz-Bodalska K; Wiela-Hojeńska A
    Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical observation of the adverse drug reactions caused by non-ionic iodinated contrast media: results from 109,255 cases who underwent enhanced CT examination in Chongqing, China.
    Li X; Chen J; Zhang L; Liu H; Wang S; Chen X; Fang J; Wang S; Zhang W
    Br J Radiol; 2015 Mar; 88(1047):20140491. PubMed ID: 25582519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and severity of nonionic low-osmolar iodinated contrast medium-related adverse drug reactions in the Republic of Korea: Comparison by generic.
    Jang EB; Suh CH; Kim PH; Kim AY; Do KH; Lee JH; Gwon DI; Jung AY; Lee CW
    Medicine (Baltimore); 2023 May; 102(19):e33717. PubMed ID: 37171360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of the incidence of hypersensitivity reactions and post-contrast acute kidney injury after ioversol in more than 57,000 patients: part 1-intravenous administration.
    van der Molen AJ; Dekkers IA; Bedioune I; Darmon-Kern E
    Eur Radiol; 2022 Aug; 32(8):5532-5545. PubMed ID: 35312790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Adverse Reactions to Nonionic Iodinated Contrast Media: A Meta-Analysis.
    Suh YJ; Yoon SH; Hong H; Hahn S; Kang DY; Kang HR; Choi YH; Lee W
    Invest Radiol; 2019 Sep; 54(9):589-599. PubMed ID: 30998567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical observation of adverse drug reactions to non-ionic iodinated contrast media in population with underlying diseases and risk factors.
    Li X; Liu H; Zhao L; Liu J; Cai L; Liu L; Zhang W
    Br J Radiol; 2017 Feb; 90(1070):20160729. PubMed ID: 27928926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and risk factors of iodinated contrast media (ICM)-induced anaphylaxis.
    Fukushima Y; Taketomi-Takahashi A; Suto T; Hirasawa H; Tsushima Y
    Eur J Radiol; 2023 Jul; 164():110880. PubMed ID: 37187078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and patient comfort with iodixanol: a postmarketing surveillance study in 9515 patients undergoing diagnostic CT examinations.
    Häussler MD
    Acta Radiol; 2010 Oct; 51(8):924-33. PubMed ID: 20828300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal Safety of Repeated Intravascular Administrations of Iodinated or Gadolinium-Based Contrast Media within a Short Interval.
    Kwon C; Kang KM; Choi YH; Yoo RE; Sohn CH; Han SS; Yoon SH
    Korean J Radiol; 2021 Sep; 22(9):1547-1554. PubMed ID: 34132080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin Test Reactivity Patterns in Patients Allergic to Iodinated Contrast Media: A Refined View.
    Ghiordanescu IM; Molinari N; Ciocănea-Teodorescu I; Schrijvers R; Motei C; Forsea AM; Demoly P; Chiriac AM
    J Allergy Clin Immunol Pract; 2024 Mar; 12(3):705-713.e6. PubMed ID: 39056227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breakthrough reactions of iodinated and gadolinium contrast media after oral steroid premedication protocol.
    Jingu A; Fukuda J; Taketomi-Takahashi A; Tsushima Y
    BMC Med Imaging; 2014 Oct; 14():34. PubMed ID: 25287952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate reactions to iodinated contrast media.
    Morales-Cabeza C; Roa-Medellín D; Torrado I; De Barrio M; Fernández-Álvarez C; Montes-Aceñero JF; De La Riva I; Prieto-García A
    Ann Allergy Asthma Immunol; 2017 Dec; 119(6):553-557. PubMed ID: 29017901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate Mild Reactions to CT with Iodinated Contrast Media: Strategy of Contrast Media Readministration without Corticosteroids.
    Park SJ; Kang DY; Sohn KH; Yoon SH; Lee W; Choi YH; Cho SH; Kang HR
    Radiology; 2018 Sep; 288(3):710-716. PubMed ID: 29786483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
    Cheruvu B; Henning K; Mulligan J; Klippenstein D; Lawrence D; Gurtoo L; Gottlieb RH
    J Comput Assist Tomogr; 2007; 31(4):493-8. PubMed ID: 17882021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.